aspirin has been researched along with glucuronyl glucosamine glycan sulfate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andriuoli, G; Barbanti, M; Mastacchi, R | 1 |
| Franzosi, MG; Fresco, C; Maggioni, AP; Tognoni, G | 1 |
| Agus, G; Arpaia, G; Belcaro, G; Cesarone, MR; Cornelli, U; Corsi, M; Cotellese, R; Dugall, M; Errichi, BM; Hosoi, M; Hu, S; Ippolito, E; Ledda, A; Luzzi, R; Ricci, A | 1 |
| Shen, Y; Xu, G; Yan, W; Zhou, B | 1 |
| Belcaro, G; Cesarone, MR; Cornelli, U; Corsi, M; Cotellese, R; Dugall, M; Errichi, BM; Feragalli, B; Hosoi, M; Hu, S; Ippolito, E; Ledda, A; Ricci, A | 1 |
| Belcaro, G; Bradford, HD; Cesarone, MR; Cotellese, R; Dugall, M; Feragalli, B; Gizzi, C; Hosoi, M; Hu, S; Rodriguez, P | 1 |
| Imberti, D; Mastroiacovo, D; Pomero, F | 1 |
| Jo, WM; Kim, JW; Kim, TS; Sohn, SH; Yoo, SM | 1 |
2 review(s) available for aspirin and glucuronyl glucosamine glycan sulfate
| Article | Year |
|---|---|
Antioxidant and antithrombotic therapies for diabetic kidney disease.
Topics: Antioxidants; Aspirin; Diabetic Nephropathies; Endopeptidases; Fibrinolytic Agents; Glycated Hemoglobin; Glycosaminoglycans; Humans; Phytotherapy; Plant Preparations; Tissue Kallikreins; Tripterygium | 2015 |
Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Dabigatran; Glycosaminoglycans; Hemorrhage; Humans; Middle Aged; Pyrazoles; Pyridones; Recurrence; Risk Factors; Rivaroxaban; Treatment Outcome; Venous Thromboembolism; Vitamin K | 2020 |
1 trial(s) available for aspirin and glucuronyl glucosamine glycan sulfate
| Article | Year |
|---|---|
The efficacy of sulodexide in the prevention of postthrombotic syndrome.
Topics: Adult; Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Glycosaminoglycans; Humans; Incidence; Male; Middle Aged; Postthrombotic Syndrome; Time Factors | 2014 |
5 other study(ies) available for aspirin and glucuronyl glucosamine glycan sulfate
| Article | Year |
|---|---|
Antithrombotic activity of a glycosaminoglycan (sulodexide) in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Aspirin; Blood Platelets; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Hypolipidemic Agents; Male; Rats; Rats, Inbred Strains; Thrombosis | 1984 |
Ethical committees and noninformed consent.
Topics: Aspirin; Ethics Committees; Glycosaminoglycans; Humans; Hypolipidemic Agents; Informed Consent; Myocardial Infarction; Randomized Controlled Trials as Topic | 1994 |
Prevention of recurrent venous thrombosis and post-thrombotic syndrome.
Topics: Aspirin; Drug Therapy, Combination; Female; Fibrinolytic Agents; Flavonoids; Glycosaminoglycans; Humans; Incidence; Male; Middle Aged; Plant Extracts; Platelet Aggregation Inhibitors; Postthrombotic Syndrome; Recurrence; Registries; Retrospective Studies; Ticlopidine; Venous Thrombosis | 2018 |
Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide.
Topics: Adult; Aspirin; Female; Fibrinolytic Agents; Flavonoids; Glycosaminoglycans; Humans; Incidence; Male; Middle Aged; Plant Extracts; Platelet Aggregation Inhibitors; Recurrence; Registries; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Ticlopidine | 2019 |
Anti-thrombotic and anti-inflammatory activity of sulodexide compared to aspirin in the rat model.
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Disease Models, Animal; Glycosaminoglycans; Humans; Inflammation; Male; Rats; Rats, Sprague-Dawley; Thrombosis | 2021 |